These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10774796)

  • 21. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. K+ channel blockade in the prevention of ventricular fibrillation in dogs with acute ischemia and enhanced sympathetic activity.
    Vanoli E; Hull SS; Adamson PB; Foreman RD; Schwartz PJ
    J Cardiovasc Pharmacol; 1995 Dec; 26(6):847-54. PubMed ID: 8606519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electromechanical action of dofetilide and D-sotalol during simulated metabolic acidosis in isolated guinea pig ventricular muscle.
    Yang T; Tande PM; Refsum H
    J Cardiovasc Pharmacol; 1992 Dec; 20(6):889-94. PubMed ID: 1282590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of sotalol on arrhythmias and electrophysiology during myocardial ischaemia and reperfusion.
    Culling W; Penny WJ; Sheridan DJ
    Cardiovasc Res; 1984 Jul; 18(7):397-404. PubMed ID: 6744360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relevance of inter- and intraventricular electrical dispersion to arrhythmogenesis in normal and ischaemic rabbit myocardium: a study with cromakalim, 5-hydroxydecanoate and glibenclamide.
    Wolk R; Cobbe SM; Kane KA; Hicks MN
    J Cardiovasc Pharmacol; 1999 Feb; 33(2):323-34. PubMed ID: 10028944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of electrical heterogeneity impairs ventricular defibrillation: an effect specific to regional conduction velocity slowing.
    Ujhelyi MR; Sims JJ; Miller AW
    Circulation; 1999 Dec 21-28; 100(25):2534-40. PubMed ID: 10604892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrophysiologic basis for the antiarrhythmic actions of sotalol and comparison with other agents.
    Singh BN
    Am J Cardiol; 1993 Aug; 72(4):8A-18A. PubMed ID: 8346731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of a new amiodarone-like agent, SR 33589, in comparison to amiodarone, D,L-sotalol, and lignocaine, on ischemia-induced ventricular arrhythmias in anesthetized pigs.
    Finance O; Manning A; Chatelain P
    J Cardiovasc Pharmacol; 1995 Oct; 26(4):570-6. PubMed ID: 8569217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maintenance of intercellular coupling by the antiarrhythmic peptide rotigaptide suppresses arrhythmogenic discordant alternans.
    Kjølbye AL; Dikshteyn M; Eloff BC; Deschênes I; Rosenbaum DS
    Am J Physiol Heart Circ Physiol; 2008 Jan; 294(1):H41-9. PubMed ID: 17982010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention by calcium antagonists of profibrillatory effects of class I antiarrhythmic drugs in acute myocardial ischemia: study in pig heart in situ.
    Bui-Xuan B; Aupetit JF; Freysz M; Faucon G; Timour Q
    Pharmacotherapy; 1997; 17(4):737-45. PubMed ID: 9250551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. d-Sotalol: a new potent class III anti-arrhythmic agent.
    Taggart P; Sutton P; Donaldson R
    Clin Sci (Lond); 1985 Nov; 69(5):631-6. PubMed ID: 4053517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of MS-551, a new class III antiarrhythmic drug, on action potential and membrane currents in rabbit ventricular myocytes.
    Nakaya H; Tohse N; Takeda Y; Kanno M
    Br J Pharmacol; 1993 May; 109(1):157-63. PubMed ID: 7684298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reproducible induction of early afterdepolarizations and torsade de pointes arrhythmias by d-sotalol and pacing in dogs with chronic atrioventricular block.
    Vos MA; Verduyn SC; Gorgels AP; Lipcsei GC; Wellens HJ
    Circulation; 1995 Feb; 91(3):864-72. PubMed ID: 7828315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amplified effects of d,l-sotalol in canine dilated cardiomyopathy.
    Chugh SS; Johnson SB; Packer DL
    Pacing Clin Electrophysiol; 2001 Dec; 24(12):1783-8. PubMed ID: 11817813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Arrhythmogenicity of antiarrhythmic drugs and intraventricular conduction disorders: possible aggravation by myocardial ischemia--study in the porcine in situ heart.
    Aupetit JF; Timour Q; Larbre JP; Loufoua-Moundanga J; Kioueh I; Lopez M; Faucon G
    Cardiovasc Drugs Ther; 1993 Apr; 7(2):217-23. PubMed ID: 8357775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective Ik blocker almokalant exhibits class III--specific effects on the repolarization and refractoriness of the human heart: a study of healthy volunteers using right ventricular monophasic action potential recordings.
    Darpö B; Vallin H; Almgren O; Bergstrand R; Insulander P; Edvardsson N
    J Cardiovasc Pharmacol; 1995 Oct; 26(4):530-40. PubMed ID: 8569212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isoproterenol antagonizes drug-induced prolongation of action potential duration in humans.
    Newman D; Dorian P; Feder-Elituv R
    Can J Physiol Pharmacol; 1993; 71(10-11):755-60. PubMed ID: 8143233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacologic basis of the antiarrhythmic and hemodynamic effects of sotalol.
    Antonaccio MJ; Gomoll A
    Am J Cardiol; 1993 Aug; 72(4):27A-37A. PubMed ID: 8346723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Electrophysiologic mechanisms of antiarrhythmic efficacy of a sotalol and class Ia drug combination: elimination of reverse use dependence.
    Lee SD; Newman D; Ham M; Dorian P
    J Am Coll Cardiol; 1997 Jan; 29(1):100-5. PubMed ID: 8996301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of interventricular dispersion of repolarization in acquired torsade-de-pointes arrhythmias: reversal by magnesium.
    Verduyn SC; Vos MA; van der Zande J; van der Hulst FF; Wellens HJ
    Cardiovasc Res; 1997 Jun; 34(3):453-63. PubMed ID: 9231028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.